Bath & Body Works, Inc. (BBWI)
| Market Cap | 4.61B |
| Revenue (ttm) | 7.25B |
| Net Income (ttm) | 727.00M |
| Shares Out | 201.56M |
| EPS (ttm) | 3.53 |
| PE Ratio | 6.18 |
| Forward PE | 8.01 |
| Dividend | $0.80 (3.50%) |
| Ex-Dividend Date | Jun 5, 2026 |
| Volume | 6,573,440 |
| Open | 21.86 |
| Previous Close | 21.82 |
| Day's Range | 21.74 - 23.02 |
| 52-Week Range | 14.28 - 33.96 |
| Beta | 1.39 |
| Analysts | Hold |
| Price Target | 25.64 (+12.16%) |
| Earnings Date | May 27, 2026 |
About BBWI
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the... [Read more]
Financial Performance
In fiscal year 2026, Bath & Body Works's revenue was $7.29 billion, a decrease of -0.22% compared to the previous year's $7.31 billion. Earnings were $649.00 million, a decrease of -18.67%.
Financial StatementsAnalyst Forecast
According to 17 analysts, the average rating for BBWI stock is "Hold." The 12-month stock price target is $25.64, which is an increase of 12.16% from the latest price.
News
Bath & Body Works Turns to Ulta to Boost Product Discovery
Bath & Body Works has teamed with Ulta Beauty to bring its products to the retailer's stores. The partnership, announced Tuesday (June 23), is designed to bring a “curated” selection of Bath & Body Wo...
Bath & Body Works enters strategic partnership with Ulta Beauty
Bath & Body Works (BBWI) announced a strategic partnership with Ulta Beauty (ULTA), bringing a curated selection of its body care and home fragrance products to more than 600 Ulta…
Bath & Body Works Expands Reach with Nationwide Launch at Ulta Beauty
The strategic partnership advances Consumer First Formula strategy to reach new consumers with a curated assortment in 600+ Ulta Beauty stores and on Ulta.com The strategic partnership advances Consum...
Bath & Body Works price target raised to $26 from $25 at Wells Fargo
Wells Fargo raised the firm’s price target on Bath & Body Works to $26 from $25 and keeps an Overweight rating on the shares. Although bearish investors remain focused on…
Bath & Body Works partners with Ulta Beauty as it looks to boost sales
Ulta Beauty shoppers will soon be able to purchase Bath & Body Works' signature fragrances, hand soaps and candles in more than 600 stores from July 12 as both companies pursue turnaround plans that...
LandBridge Forms Special Committee to Evaluate Potential Corporate Conversion
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB) (the “Company” or “LandBridge”) today announced that its board of directors has formed a special committee of independent directors to evalu...
Bath & Body Works' Strategy to Win More Younger Consumers
The company's CEO Daniel Heaf says he wants to improve products, hire more influencers, update stores and revamp digital sales.
Bath & Body Works Transcript: AGM 2026
The meeting approved all board proposals, highlighted a successful CEO transition, and detailed a multi-year transformation strategy focused on innovation, cost savings, and global brand growth. Early results show double-digit product growth and strong shareholder returns.
Bath & Body Works price target lowered to $23 from $26 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on Bath & Body Works to $23 from $26 and keeps a Neutral rating on the shares. Body care sales fell in the…
Bath & Body Works price target lowered to $22 from $25 at Telsey Advisory
Telsey Advisory analyst Dana Telsey lowered the firm’s price target on Bath & Body Works to $22 from $25 and keeps a Market Perform rating on the shares. The firm…
Bath & Body Works price target raised to $25 from $20 at TD Cowen
TD Cowen analyst Jonna Kim raised the firm’s price target on Bath & Body Works to $25 from $20 and keeps a Buy rating on the shares. The firm said…
Bath & Body Works price target lowered to $25 from $29 at Wells Fargo
Wells Fargo lowered the firm’s price target on Bath & Body Works to $25 from $29 and keeps an Overweight rating on the shares. While bears had been calling for…
Bath & Body Works price target lowered to $23 from $26 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on Bath & Body Works to $23 from $26 and keeps a Neutral rating on the shares. While Q1 offered some early green…
Bath & Body Works price target lowered to $23 from $25 at Barclays
Barclays analyst Adrienne Yih lowered the firm’s price target on Bath & Body Works to $23 from $25 and keeps an Equal Weight rating on the shares post the Q1…
Bath & Body Works rises 15.8%
Bath & Body Works (BBWI) is up 15.8%, or $2.81 to $20.54.
Bath & Body Works Earnings Call Transcript: Q1 2027
Net sales declined 3.2% year-over-year, with adjusted EPS of $0.32, both ahead of expectations. Body care was the main drag, but innovation and digital expansion, including Amazon, are showing early positive signs. Full-year guidance is reaffirmed.
Bath & Body Works Earnings release: Q1 2027
Bath & Body Works released its Q1 2027 earnings on May 27, 2026, summarizing the period's financial results.
Bath & Body Works Slides: Q1 2027
Bath & Body Works has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on May 27, 2026.
Bath & Body Works Quarterly report: Q1 2027
Bath & Body Works has published its Q1 2027 quarterly earnings report on May 27, 2026.
Bath & Body Works reports Q1 adjusted EPS 32c, consensus 29c
Reports Q1 revenue $1.4B, consensus $1.36B. Daniel Heaf, chief executive officer of Bath & Body Works, commented, “Our first-quarter results exceeded guidance, but remain below the standard our brand ...
Bath & Body Works sees Q2 EPS 20c-25c, consensus 20c
For the second quarter of 2026, the company is forecasting net sales to decline between 3%-5% compared to $1.549B in the second quarter of 2025, consensus $1.49B. Published first on…
Bath & Body Works backs FY26 adjusted EPS view $2.40-$2.65, consensus $2.63
The company is maintaining its full-year 2026 guidance of net sales to decline between 2.5%-4.5% compared to $7.291B in fiscal 2025, consensus $7.08B.
Bath & Body Works CFO Eva Boratto to step down effective June 12
CFO Eva Boratto will step down from her role effective June 12 to pursue another professional opportunity. The company has initiated a comprehensive search process, supported by a leading executive…
Bath & Body Works Sales Fall Amid Turnaround Efforts
Bath & Body Works reported lower first-quarter sales as the company overhauls its strategy in an attempt to return to growth.
Bath & Body Works Reports First Quarter Results Exceeding Guidance and Progress Against the Consumer First Formula
Delivers Q1 net sales and adjusted earnings per share results above guidance First quarter net sales of $1.4 billion, down 3%. Earnings per diluted share of $0.90; Adjusted earnings per diluted share ...